STOCK TITAN

Interlink Electronics, Inc. Announces the Strategic Hire of Mark Duarte as Director of Business Development, North America

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Interlink Electronics (Nasdaq: LINK) announced the appointment of Mark Duarte as Director of Business Development, North America, effective Jan 12, 2026.

Duarte brings over 30 years of experience, including 22 years in sales, strategic planning, and execution, most recently as Senior Sales Manager at Linxens Healthcare. He will support Interlink’s organic growth strategy across the Americas by implementing strategic plans, expanding the company footprint, and pursuing multi-year, high-margin opportunities.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

-2.07%
1 alert
-2.07% News Effect

On the day this news was published, LINK declined 2.07%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Industry experience: over 30 years Sales and strategy tenure: 22 years
2 metrics
Industry experience over 30 years Career experience of Mark Duarte
Sales and strategy tenure 22 years Experience in sales, strategic planning, and execution

Market Reality Check

Price: $3.68 Vol: Volume 30,472 vs 20-day a...
low vol
$3.68 Last Close
Volume Volume 30,472 vs 20-day average 52,940 (relative volume 0.58x) ahead of the announcement. low
Technical Shares at 3.87, trading below the 200-day MA of 4.86 and well under the 10.10 52-week high.

Peers on Argus

LINK traded flat while one momentum-screened peer, OPTX, moved 9.96% up without ...
1 Up

LINK traded flat while one momentum-screened peer, OPTX, moved 9.96% up without news. Broader peers (GAUZ, NEON, ELTK, HOLO, RELL) showed mixed moves, suggesting the executive hire news was company-specific rather than part of a sector-wide shift.

Historical Context

5 past events · Latest: Jan 05 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
Jan 05 Leadership hire Positive -4.4% Appointed European Business Development Director to drive organic growth in Europe.
Nov 12 Earnings update Positive -0.2% Reported Q3 2025 revenue growth, margin improvement, and a narrower net loss.
Oct 20 Conference presentation Positive +12.3% LD Micro presentation highlighting SBIR grant, U.K. LOI, and capital structure changes.
Oct 16 Conference announcement Positive -2.3% Announced upcoming LD Micro appearance and planned investor meetings in San Diego.
Oct 15 Capital structure change Positive -16.4% Mandatory conversion of 8.00% Series A Preferred into common shares at 3-for-1 ratio.
Pattern Detected

Recent history shows several positive corporate updates followed by negative or flat next-day moves, with only one event showing a strong positive alignment.

Recent Company History

Over the last few months, Interlink reported multiple growth-focused developments. In Q3 2025, revenue reached $2.96M, up 10.8% YoY, with gross margin at 41.8% and a narrowed net loss of $336k. The company converted all Series A preferred into common, following a prior 3-for-1 conversion ratio trigger at $10.00 per share. It also highlighted a $200,000 FDA SBIR grant and a U.K. acquisition LOI. On Jan 5, 2026, it made a parallel strategic hire in Europe, similar in nature to today’s North America business development appointment.

Market Pulse Summary

This announcement adds another experienced business development leader as Interlink pursues organic ...
Analysis

This announcement adds another experienced business development leader as Interlink pursues organic growth, mirroring a similar European hire on Jan 5, 2026. It arrives after periods of revenue growth, improved margins, and capital structure simplification through preferred stock conversion. With shares at 3.87, below the 200-day MA of 4.86 and far from the 10.10 52-week high, investors may watch how this role contributes to execution in North America and complements prior strategic and regulatory developments.

Key Terms

biosensors
1 terms
biosensors medical
"product design, development, and high-value contract manufacturing for Medical Device Wearables, Biosensors, and trace"
Biosensors are devices that use a biological element (like an enzyme or antibody) combined with a detector to identify and measure molecules such as glucose, pathogens or biomarkers. Think of them as a smoke detector for specific chemicals or biological signals; they turn a biological reaction into a readable signal. Investors care because biosensors can drive recurring revenue from diagnostics, monitoring and wearable health devices, and their commercial value depends on accuracy, manufacturing scale and regulatory approval.

AI-generated analysis. Not financial advice.

FREMONT, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Interlink Electronics, Inc. (Nasdaq: LINK), a global leader in sensor technology and printed electronics solutions, has announced the appointment of Mark Duarte as the Director of Business Development, North America.

The Director of Business Development position supports Interlink’s organic growth strategy across the Americas. Duarte will play a crucial role in implementing the company’s strategic growth plan and further expanding its footprint across the Americas.

Duarte joins Interlink with over 30 years of experience, including 22 years in sales, strategic planning, and execution. Most recently, he served as the Senior Sales Manager at Linxens Healthcare, a multi-national corporation providing product design, development, and high-value contract manufacturing for Medical Device Wearables, Biosensors, and trace & authentication devices. Duarte focused on aligning sales efforts with corporate growth strategies across the Americas and consistently exceeded revenue targets. He managed complex negotiations, securing multi-year contracts and high-margin deals.

Before joining Linxens Healthcare, Duarte served as the Director of Medical Sales at East West MFG., where he helped establish the company as a premier contract manufacturer in the medical device market. Duarte spearheaded growth and managed medical sales, driving the business's growth. He secured recurring design-production businesses with major OEMs and established a steady stream of prospects and new customers for East West MFG’s medical marketing businesses.

“We are excited to welcome Mark Duarte to the Interlink team,” said Steven N. Bronson, CEO of Interlink Electronics. “Mark’s extensive experience in sales leadership, strategic execution, and knowledge of the medical device market make him an ideal fit to continue our organic growth strategy across North America.”

About Interlink Electronics, Inc.
Interlink Electronics is a leading provider of sensors and printed electronic solutions, boasting 40 years of success in delivering mission-critical technologies across diverse markets. Our customers, including global blue-chip companies, trust our products and solutions, which span various markets, including medical, industrial, automotive, wearables, IoT, and other specialty markets. Our expertise in materials science, manufacturing, embedded electronics, firmware, and software enables us to create custom solutions tailored to our customers’ unique needs.

We serve our international customer base from our corporate headquarters and proprietary gas sensor production and product development facility in Fremont, California (Silicon Valley area); our Global Product Development and Materials Science Center and distribution and logistics center in Camarillo, California; and our advanced printed-electronics manufacturing facilities in Shenzhen, China; Irvine, Scotland; and Barnsley, England. For more information, please visit www.InterlinkElectronics.com.

Forward Looking Statements
This release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be generally identified by phrases such as “thinks,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” and similar words. Forward-looking statements in our press releases include statements about our projected financial and operating performance, our acquisition program, our strategy and prospects, and our opportunities for organic growth and synergies. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statement. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management’s own knowledge and assessment of the company’s industry, R&D initiatives, competition and capital requirements. Other factors and uncertainties that could affect the company’s forward-looking statements include, among other things, the following: our success in predicting new markets and the acceptance of our new products; efficient management of our infrastructure; the pace of technological developments and industry standards evolution and their effect on our target product and market choices; the effect of outsourcing technology development; changes in the ordering patterns of our customers; a decrease in the quality and/or reliability of our products; protection of our proprietary intellectual property; competition by alternative sophisticated as well as generic products; continued availability of raw materials for our products at competitive prices; disruptions in our manufacturing facilities; risks of international sales and operations including fluctuations in exchange rates and tariffs; compliance with regulatory requirements applicable to our manufacturing operations; and customer concentrations. Additional factors that could cause actual results to differ materially from those anticipated by our forward-looking statements are described under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our most recent Annual Report (Form 10-K) or Quarterly Report (Form 10-Q) filed with the Securities and Exchange Commission. Forward-looking statements are made as of the date of the respective release, and we expressly disclaim any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Company Contact:
Interlink Electronics, Inc.
Steven N. Bronson, CEO
LINK@IESensors.com  
805-623-4184


FAQ

Who is Mark Duarte and what role did he accept at Interlink Electronics (LINK)?

Mark Duarte was hired as Director of Business Development, North America at Interlink Electronics (LINK), announced Jan 12, 2026.

How does Mark Duarte’s background support Interlink Electronics’ growth plans (LINK)?

Duarte has over 30 years of experience and 22 years in sales and strategic execution, including multi-year contract negotiations and high-margin deals in medical device markets.

What will Mark Duarte be responsible for as Director of Business Development at Interlink (LINK)?

He will implement the company’s organic growth plan across the Americas, expand Interlink’s footprint in North America, and pursue strategic, high-margin opportunities.

When was Interlink Electronics’ appointment of Mark Duarte announced for LINK?

The appointment was announced on January 12, 2026.

How might investors view the hire of Mark Duarte at Interlink Electronics (LINK)?

The hire signals a focus on executing organic growth across the Americas by adding experienced business development leadership with medical device sales expertise.
Interlink Electrs Inc

NASDAQ:LINK

LINK Rankings

LINK Latest News

LINK Latest SEC Filings

LINK Stock Data

59.38M
3.40M
83.43%
1.32%
0.22%
Electronic Components
Computer Peripheral Equipment, Nec
Link
United States
FREMONT